Ad is loading...
CGFCX
Price
$69.21
Change
-$1.16 (-1.65%)
Updated
Nov 15 closing price
RGACX
Price
$77.24
Change
-$1.30 (-1.66%)
Updated
Nov 15 closing price
Ad is loading...

CGFCX vs RGACX

Header iconCGFCX vs RGACX Comparison
Open Charts CGFCX vs RGACXBanner chart's image
American Funds Growth Fund of Amer 529C
Price$69.21
Change-$1.16 (-1.65%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R3
Price$77.24
Change-$1.30 (-1.66%)
VolumeN/A
CapitalizationN/A
CGFCX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CGFCX vs. RGACX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGFCX is a StrongBuy and RGACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
CGFCX (298B) and RGACX (298B) have equal amount of cash in the bank . RGACX pays higher dividends than CGFCX: RGACX (0.25) vs CGFCX (0.00). CGFCX was incepted earlier than RGACX: CGFCX (23 years) vs RGACX (23 years). CGFCX (31.00) and RGACX (31.00) have comparable annual turnover. CGFCX (250) and RGACX (250) have matching initial minimum investment requirements. RGACX annual gain was more profitable for investors over the last year : 27.34 vs. CGFCX (25.84). RGACX return over 5 years is better than : 51.21 vs. CGFCX (44.46).
CGFCXRGACXCGFCX / RGACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD25.60826.12798%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets298B298B100%
Annual Yield % from dividends0.000.25-
Returns for 1 year25.8427.3494%
Returns for 3 years-8.49-5.45156%
Returns for 5 years44.4651.2187%
Returns for 10 years53.8766.9980%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WEYS38.891.07
+2.83%
Weyco Group
IDA117.190.45
+0.39%
IDACORP
SYY74.95-0.01
-0.01%
Sysco Corp
COLL29.58-0.69
-2.28%
Collegium Pharmaceutical
LEXX2.01-0.11
-5.19%
Lexaria Bioscience Corp